 |
Prime Policy Group is repping Britain’s AstraZeneca on COVID-19 vaccine and therapy development.
The Food and Drug Administration has not approved AstraZeneca’s vaccine for emergency use in the US, as it did for shots developed by Johnson & Johnson, Moderna and Pfizer.
The Biden administration plans to donate 60M doses of AstraZeneca vaccine to India and other countries that have been hit hard by the pandemic. It already has sent 4M AstraZeneca shots to Canada and Mexico.
Prime Policy Group’s CEO Scott Pastrick, chairman Charlie Black and vice chairman Rich Meade are part of the AstraZeneca team.
It works for AstraZeneca as a subcontractor to sister WPP company, BCW.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
